Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy on Ultra-central Lung Tumors on MR-Linac

NCT07733219 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Ultracentral Pulmonary Tumors
Lung Cancer (T1 N0 M0 and T2 N0 M0)
Mediastinal Lymph Node Recurrence From All Types of Primary Cancer
Pulmonary Node Recurrence From All Types of Primary Cancer

Interventions

RADIATION: MRI-LINAC radiotherapy

Sponsor

Centre Oscar Lambret

Collaborators

[object Object]
[object Object]